明源雲(00909.HK)預期年度經調整淨利潤3.3億至3.9億元
格隆匯1月22日丨明源雲(00909.HK)發佈公吿,截至2020年12月31日止年度,預期將錄得公司股東應占虧損約人民幣6.9億元至約人民幣7.5億元(截至2019年12月31日止年度:公司股東應占利潤約人民幣2.16億元),該虧損主要由於確認優先股的公允價值虧損約人民幣9.89億元造成。差額已於2020年計入損益內。因此,於計算經調整淨利潤時撇銷相關項目(包括差額)的影響可更好地反映集團的相關經營業績,並有助於進行期間比較;及截至2020年12月31日止年度,集團預期將錄得經調整淨利潤約人民幣3.3億元至人民幣3.9億元(截至2019年12月31日止年度:經調整淨利潤約人民幣2.36億元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.